Where does Triveni Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Triveni Bio's 2 recorded funding rounds.

Premier Alternatives

Triveni Bio

Drug Discovery · Watertown, MA · Founded 2019 · Privately Held (backing)

Developer of a clinical-stage biotechnology company designed to create antibody-based therapies targeting immunological and inflammatory diseases. Triveni Bio is based in Watertown, MA and was founded in 2019. It is valued at about $398 million as of Oct 2026, set by institutional fund marks, up 28% since its later-stage round in Jun 2025. It has raised $232 million across 2 recorded rounds; the latest was an $115 million Series B in Jun 2025.

PMV mark · valuation

$398.1M

Oct 2026

Since last round

+28%

Jun 2025

Total raised

$231.6M

Last round

Later Stage VC (Series B)

Jun 2025

Cap table — not yet on record

Triveni Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Pro

The prices on Triveni Bio

·6 fund marks: filer, period, implied $/share

Pro · $99 a month

List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Frequently asked about Triveni Bio

Where does Triveni Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Triveni Bio's 2 recorded funding rounds.